These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 121666)

  • 21. Early plasma cell recruitment in multiple myeloma following chemotherapy.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R
    Cell Tissue Kinet; 1988 Nov; 21(6):405-9. PubMed ID: 3251633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A man with generalized weakness.
    Dalfardi B
    Eur J Intern Med; 2018 May; 51():e7-e8. PubMed ID: 28693943
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors.
    Sonneveld P; Schoester M; de Leeuw K
    Br J Haematol; 1991 Dec; 79(4):589-94. PubMed ID: 1772780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin E (IgE) multiple myeloma: a case report and review of the literature.
    Endo T; Okumura H; Kikuchi K; Munakata J; Otake M; Nomura T; Asakawa H
    Am J Med; 1981 May; 70(5):1127-32. PubMed ID: 7015852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1974 Dec; 57(6):927-39. PubMed ID: 4611209
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract]   [Full Text] [Related]  

  • 28. 'Mu' heavy chain type 'non-excretory' myeloma.
    Guglielmo P; Granata P; Di Raimondo F; Lombardo T; Giustolisi R; Cacciola E
    Scand J Haematol; 1982 Jul; 29(1):36-40. PubMed ID: 6812210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgD myeloma with myelofibrosis and amyloidosis.
    Udoji WC; Pemmaraju S
    Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature.
    Hütter G; Nowak D; Blau IW; Thiel E
    Int J Lab Hematol; 2009 Apr; 31(2):236-40. PubMed ID: 18190590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.
    Grogan TM
    Semin Diagn Pathol; 2003 Aug; 20(3):211-25. PubMed ID: 14552432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heavy chain loss after treatment with Melphalan in a patient with "nonsecretory" myeloma.
    Katagiri S; Yonezawa T; Kanayama Y; Tsubakio T; Tamaki T; Kanakura Y; Kurata Y; Tarui S
    Blut; 1983 Feb; 46(2):73-80. PubMed ID: 6401436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
    Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
    Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple myeloma and acute leukemia. Simultaneous evolution of plasmacyte and myelomonocytic clones].
    Renoux M; Bernard JF; Bezeau A; Amar M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):809-13. PubMed ID: 214859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
    Maachi M; Fellahi S; Diop ME; Francois T; Capeau J; Bastard JP
    Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential therapy compared with combination therapy in multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
    Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA
    Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic conference: Multiple malignancies: chronic lymphocytic leukemia, malignant melanoma, multiple myeloma and acute myelomonocytic leukemia.
    Am J Med; 1975 Mar; 58(3):408-16. PubMed ID: 1054212
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular kinetics staging, and immunoglobulin synthesis in multiple myeloma.
    Durie BG; Salmon SE
    Annu Rev Med; 1975; 26():283-8. PubMed ID: 1096765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.